![]() |
|
|
Molecular Pharmacology, Vol 2, 481-490, Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics
1 Departments of Pharmacology and Biochemistry and the Cardiovascular Research
Institute, School of Medicine, University of California, San Francisco Medical
Center, San Francisco, California 94122
An in vitro system composed of isolated rat liver mitochondria and an AMP deaminase-containing
cytoplasmic protein fraction has been employed for the study of the effect of uncouplers on the
enzymic conversion of ATP to IMP + NH4+. Under these conditions one main pathway of
ATP degradation is operative. It was shown that this metabolic sequence is initiated by activation of latent mitochondrial ATPase by uncouplers. Under uncoupled conditions, mitochondrial adenylate kinase converts ADP to AMP, which is almost quantitatively converted to IMP + NH4+
by cytoplasmic AMP deaminase. Oligomycin, which has no effect on AMP deaminase or adenylate
kinase but counteracts the activating effect of uncouplers on mitochondrial ATPase, inhibits the
ATP
IMP + NH4+ pathway by blocking the initiating step. An ATP-dependent activation of
AMP-deaminase by Mg++ has been demonstrated. Relevance of these mechanisms to molecular
control of cellular events is discussed.
Note:
ACKNOWLEDGMENTS
This work was supported by research grants
of the U.S. Public Health Service, RO1-CA-07955-03 and RO1-HD-01239-10, and of the
National Science Foundation, GB-3488, and in
part by U.S. Public Health Service training
grant 2-T1-GM-475-06 (to Dr. El-Fiky).